Lantern Pharma Investor Relations Material
Latest events
Q4 2023
Lantern Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Lantern Pharma Inc
Access all reports
Lantern Pharma is a clinical stage biotechnology company whose clinical programs target patients that have limited or poor options. Lantern's revolutionary AI platform, RADR®, uses leading edge machine learning techniques to help optimize drug development and clinical trial design, identify potential new indications for approved drugs, and improve the success of oncology clinical trials.
Key slides for Lantern Pharma Inc
Q4 2023
Lantern Pharma Inc
Q4 2023
Lantern Pharma Inc
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States